"Separating contenders from
pretenders in breast cancer"

-- ASCO Post

"Blazes a trail in breast cancer"

-- Nature Biotechnology

"A glimpse into the future of
phase II drug development?"

-- NEJM
Close
Close
I-SPY Email List Sign-up

What's new at I-SPY?

What is I-SPY?

The I-SPY series of trials are changing the way new treatments are developed for breast cancer, helping make available new, better and more personalized treatments, faster. At the heart of the I-SPY program is the ground-breaking I-SPY2 platform trial for neoadjuvant treatment of locally advanced breast cancer.

1300
patients enrolled
13
agents completed
evaluation since 2010
3
agents received
accelerated approval
Find out more

World-class science requires world-class scientists.

Meet some of our team

I-SPY is supported by: